These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 16315337

  • 1. Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention.
    Kvan E, Pettersen KI, Landmark K, Reikvam A, INPHARM study investigators.
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):261-7. PubMed ID: 16315337
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A, D'Ambrosio G, Giustini SE, Pecchioli S, Mazzaglia G, Cricelli C.
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [Abstract] [Full Text] [Related]

  • 3. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A.
    Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
    [Abstract] [Full Text] [Related]

  • 4. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
    Fernandes AW, Madhavan SS, Amonkar MM.
    Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
    [Abstract] [Full Text] [Related]

  • 5. Drug insight: Statin use in the elderly.
    Raffel OC, White HD.
    Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):318-28. PubMed ID: 16729010
    [Abstract] [Full Text] [Related]

  • 6. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L.
    Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
    [Abstract] [Full Text] [Related]

  • 7. Changes in acute myocardial infarction risk and patterns of practice for patients older and younger than 70 years, 1987-90.
    Montague TJ, Wong RY, Burton JR, Bay KS, Catellier DJ, Teo KK.
    Can J Cardiol; 1992 Mar; 8(6):596-600. PubMed ID: 1354568
    [Abstract] [Full Text] [Related]

  • 8. [Reasons for the under-use of secondary prevention therapies in coronary patients over the age of 70 years].
    Cournot M, Cambou JP, Quentzel S, Danchin N.
    Ann Cardiol Angeiol (Paris); 2005 Dec; 54 Suppl 1():S17-23. PubMed ID: 16411647
    [Abstract] [Full Text] [Related]

  • 9. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS, Bajorek BV.
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [Abstract] [Full Text] [Related]

  • 10. Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.
    Beck CA, Lauzon C, Eisenberg MJ, Huynh T, Dion D, Roux R, Racine N, Carignan S, Diodati JG, Charbonneau F, Lévesque C, Pouliot J J, Pilote L L.
    Can J Cardiol; 2001 Jan; 17(1):33-40. PubMed ID: 11173312
    [Abstract] [Full Text] [Related]

  • 11. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C, Jacobsen J, Larsen AC, Schmidt EB, Johannesen NL, Videbaek J, Sørensen HT, Johnsen SP.
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [Abstract] [Full Text] [Related]

  • 12. Missed opportunities in the secondary prevention of myocardial infarction: an assessment of the effects of statin underprescribing on mortality.
    Austin PC, Mamdani MM, Juurlink DN, Alter DA, Tu JV.
    Am Heart J; 2006 May; 151(5):969-75. PubMed ID: 16644313
    [Abstract] [Full Text] [Related]

  • 13. Statins prescribing for the secondary prevention of ischaemic heart disease in Torino, Italy. A case of ageism and social inequalities.
    Gnavi R, Migliardi A, Demaria M, Petrelli A, Caprioglio A, Costa G.
    Eur J Public Health; 2007 Oct; 17(5):492-6. PubMed ID: 17303583
    [Abstract] [Full Text] [Related]

  • 14. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M, Richard H, Pilote L.
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
    [Abstract] [Full Text] [Related]

  • 15. Four out of ten patients are not taking statins regularly during the 12 months after an acute coronary event.
    Thornley S, Marshall R, Chan WC, Kerr A, Harrison J, Jackson G, Crengle S, Wright C, Wells S, Jackson R.
    Eur J Prev Cardiol; 2012 Jun; 19(3):349-57. PubMed ID: 21450568
    [Abstract] [Full Text] [Related]

  • 16. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ, Roberts AP, Morley R, Thornley AR, Owens WA, de Belder MA.
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
    [Abstract] [Full Text] [Related]

  • 17. Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003.
    Walley T, Folino-Gallo P, Stephens P, Van Ganse E.
    Br J Clin Pharmacol; 2005 Nov; 60(5):543-51. PubMed ID: 16236045
    [Abstract] [Full Text] [Related]

  • 18. An intervention to improve secondary prevention of coronary heart disease.
    Bailey TC, Noirot LA, Blickensderfer A, Rachmiel E, Schaiff R, Kessels A, Braverman A, Goldberg A, Waterman B, Dunagan WC.
    Arch Intern Med; 2007 Mar 26; 167(6):586-90. PubMed ID: 17389290
    [Abstract] [Full Text] [Related]

  • 19. Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database.
    Tuppin P, Neumann A, Danchin N, Weill A, Ricordeau P, de Peretti C, Allemand H.
    Arch Cardiovasc Dis; 2009 Apr 26; 102(4):279-92. PubMed ID: 19427605
    [Abstract] [Full Text] [Related]

  • 20. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
    Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC.
    Am J Cardiol; 2007 Oct 01; 100(7):1061-7. PubMed ID: 17884362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.